Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

New wearable device, no bigger than a stamp, uses AI to deliver on-the-go cardiac imaging

New stamp-sized wearable device uses AI to deliver on-the-go cardiac imaging

The device, designed to be worn for up to 24 hours at a time, uses ultrasound technology and artificial intelligence to track how much blood the user's heart is pumping.

#CTA #photoncountingCT #aortaCT

Photon counting cuts CTA contrast dosage 25%

Not only does the low-volume contrast protocol preserve supplies, it also protects patients who might be vulnerable to adverse reactions and/or side effects from contrast use. 

Thumbnail

Cardiologists use video-based AI model to ID coronary artery disease

A team of specialists out of Cedars-Sinai developed the deep learning model using TTEs from nearly 3,000 patients.

Increased use of CCTA improves CAD outcomes without raising costs

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

An example if an implantable cardioverter defibrillator (ICD and its leads connected to the heart. As the leads or deveice wears out, there are recommendations to remove the leads and put in new ones. Image courtesy of RSNA

Infection, heart failure the most common reasons for early mortality after transvenous lead removal

Early mortality specifically related to complications during the TLR procedure was quite rare. 

Thumbnail

EHR intervention targets acute kidney injuries after PCI

Contrast-associated acute kidney injury is a significant problem in cardiology, especially among patients undergoing percutaneous coronary intervention. Can EHR-generated alerts make an impact?

 The Neovasc Reducer System is designed to treat the symptoms of refractory angina by altering a patient's blood flow.

Shockwave Medical to acquire medical device company for $100M

Shockwave Medical's decision to acquire Neovasc is based largely on the potential of the Neovasc Reducer System, a solution designed to treat the symptoms of refractory angina by altering a patient's blood flow.

‘Revolutionary’ new CT scans identify the most common cause of high blood pressure

Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.